Resmed Inc. buy JPMorgan Chase & Co.
Start price
24.04.25
/
50%
€208.50
Target price
24.04.26
€255.40
Performance (%)
1.73%
Price
16:16
€212.10
Summary
This prediction is currently active. With a performance of 1.73%, the BUY prediction by JPMorgan_Chase___Co_ for Resmed Inc. is trending in the right direction. This prediction currently runs until 24.04.26. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Resmed Inc. | -7.441% | -7.441% |
| iShares Core DAX® | 0.463% | -1.530% |
| iShares Nasdaq 100 | -1.792% | -5.385% |
| iShares Nikkei 225® | 5.124% | 8.053% |
| iShares S&P 500 | -1.760% | -3.821% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at JPMorgan Chase & Co. from $286.00 to $290.00. They now have an "overweight" rating on the stock.
Ratings data for RMD provided by MarketBeat